LIST OF PUBLICATIONS AND MONOGRAPHS

• Magdalena Rogalska, Paweł Rogalski, Aleksandra Andrzejuk, Agnieszka Błachnio-Zabielska, Piotr Zabielski, Robert Flisiak. Lipidome remodeling in primary biliary cholangitis. Lipids in Health and Disease, 2026: 25, 1-12. Impact Factor: 4.2
• Czajkowska Anna, Szczerbiński Łukasz, Czajkowski Marcin, Anna Citko-Rojewska, Paulina Konopka, Agnieszka Błachnio-Zabielska, Adam Krętowski, Piotr Zabielski. The impact of exercise on skeletal muscle proteome of prediabetic subjects analyzed with data independent mass spectrometry. Scientific Reports, 2025: 15, 1-21. Impact factor: 4.3

• Elżbieta Wiluk, Beata Żelazowska-Rutkowska. Described cases of parasitosis in Poland from 2014 to 2024. Diagnostics of parasitic diseases. Medical University of Bialystok, 2025, 1-37. ISBN 978-83-68268-78-2 PDF

• Monika Imierska, Piotr Zabielski, Kamila Roszczyc-Owsiejczuk, Karolina Pogodzińska, Agnieszka Błachnio-Zabielska. Impact of reduced hepatic ceramide levels in high-fat diet mice on glucose metabolism. Journal of Nutritional Biochemistry, 2025: 135, 1-13. Impact Factor: 4.9
• Kamil Myszczyński, Joanna Szuszkiewicz, Kamil Krawczyński, Małgorzata Sikora, Marta Romaniewicz, Maria M. Guzewska, Piotr Zabielski, Monika M. Kaczmarek. In-depth analysis of miRNA binding sites reveals the complex response of uterine epithelium to miR-26a-5p and miR-125b-5p during early pregnancy. Molecular & Cellular Proteomics, 2025: 24, 1-16. Impact Factor: 5.5
• Magdalena Rogalska, Agnieszka Błachnio-Zabielska, Piotr Zabielski, Jacek Janica, Kamila Roszczyc-Owsiejczuk, Karolina Pogodzińska, Aleksandra Andrzejuk, Andrzej Dąbrowski, Robert Flisiak, Paweł Rogalski. Acylcarnitine and free fatty acid profiles in primary biliary cholangitis: associations with fibrosis and inflammation. Nutrients, 2025: 17, 1-17. Impact Factor: 5.0
• Magdalena Rogalska, Agnieszka Błachnio-Zabielska, Piotr Zabielski, Jacek Janica, Kamila Roszczyc-Owsiejczuk, Karolina Pogodzińska, Aleksandra Andrzejuk, Andrzej Dąbrowski, Robert Flisiak, Paweł Rogalski. Altered sphingolipid profile in primary biliary cholangitis: associations with fibrosis and inflammation. Scientific Reports, 2025: 15, 10. Impact Factor: 3.9
• Magdalena Rogalska, Sławomir Ławicki, Agnieszka Błachnio-Zabielska, Piotr Zabielski, Kamila Roszczyc-Owsiejczuk, Jacek Janica, Dagmara Bogdanowska-Charkiewicz, Aleksandra Andrzejuk, Andrzej Dąbrowski, Robert Flisiak, Paweł Rogalski. Elevated plasma BDNF in early primary biliary cholangitis: associations with liver fibrosis, IL-6, IL-18, fatigue, and cognitive impairment. International Journal of Molecular Sciences, 2025: 26, 15, 15. Impact Factor: 4.9
• Michał Ordak, Daria Tkacz, Izabela Juzwiuk, Wiktoria Gorecka, Tadeusz Nasierowski, Elżbieta Muszyńska, Magdalena Bujalska-Zadrożny. Mephedrone and its metabolites: a narrative review. International Journal of Molecular Sciences. 2025: 26: 15, 1-15. Impact Factor: 5.6
• Piotr Zabielski, Monika Imierska, Kamila Roszczyc-Owsiejczuk, Mariusz Kuźmicki, Paweł Rogalski, Jarosław Daniluk, Agnieszka U. Błachnio-Zabielska. The Role of Acyl-CoA Synthetase 1 in Bioactive Lipid Accumulation and the Development of Hepatic Insulin Resistance. Nutrients, 2024: 16, 7, 1-15. Impact Factor: 5.8
• Anna Czajkowska, Marcin Czajkowski, Łukasz Szczerbinski, Krzysztof Jurczuk, Daniel Reska, Wojciech Kwedlo, Marek Krętowski, Piotr Zabielski, Adam Krętowski. Exploring protein relative relations in skeletal muscle proteomic analysis for insights into insulin resistance and type 2 diabetes. Scientific Reports, 2024: 14, 1, 1-20. Impact Factor: 3.8
• Adam R. Markowski, Agnieszka U. Błachnio-Zabielska, Karolina Pogodzińska, Anna J. Markowska, Piotr Zabielski. Diverse Sphingolipid Profiles in Rectal and Colon Cancer. International Journal of Medical Sciences, 2023: 24, 1-13. Impact Factor: 3.2
• Piotr Zabielski, Marta Chacińska, Karol Charkiewicz S.D., Marcin Baranowski, Jan Górski, Agnieszka Błachnio-Zabielska. Effect of metformin on bioactive lipid metabolism in insulin-resistant muscle. Journal of Endocrinology, 2017: 233, 3, 329-340. Impact Factor: 4.706
• Monika Książek [S.D], M. Charmas, A. Klusiewicz, Piotr Zabielski, B. Długołęcka, Adrian Chabowski, Marcin Baranowski. Endurance training selectively increases high-density lipoprotein-bound sphingosine-1-phosphate in the plasma. Scandinavian Journal of Medicine & Science in Sports, 2017, 8 pp. Impact Factor: 3.331
• Sarthak Matravadia, Piotr Zabielski, Adrian Chabowski, David M. Mutch, Graham P. Holloway. LA and ALA prevent glucose intolerance in obese male rats without reducing reactive lipid content, but cause tissue-specific changes in fatty acid composition. American Journal of Physiology-Regulatory Integrative and Comparative Physiology, 2016: 310, 7, R619-R630. Impact Factor: 2.982
• Dorota Harasiuk, Marcin Baranowski, Piotr Zabielski, Adrian Chabowski, Jan Górski. Liver X receptor agonist TO901317 prevents diacylglycerols accumulation in the heart of streptozotocin-diabetic rats. Cellular Physiology and Biochemistry, 2016: 39, 1, 50-359. Impact Factor: 5.104
• Piotr Laudański, Karol Charkiewicz, Rafał Kisielewski, Paweł Kuć, Ewa Koc-Żórawska, Grzegorz Raba, Janusz Kraczkowski, Violetta Dymicka-Piekarska, Adrian Chabowski, Marian Kacerovsky, Bo Jacobsson, Piotr Zabielski, Agnieszka Błachnio-Zabielska. Plasma C16-Cer levels are increased in patients with preterm labor. Prostaglandins & Other Lipid Mediators, 2016: 123, 40-45. Impact Factor: 2.640
• Agnieszka Urszula Błachnio-Zabielska, Marta Chacińska, Mikkel H. Vendelbo, Piotr Zabielski. The crucial role of C18-Cer in fat-induced skeletal muscle insulin resistance, 2016: 40, 5, 1207-1220. Impact Factor: 5.104
• Marta Chacińska, Piotr Zabielski, Sławomir Grycel, Agnieszka Błachnio-Zabielska. Udział kwasów tłuszczowych i tkanki tłuszczowej w indukowaniu insulinooporności mięśni szkieletowych. Postępy Higieny i Medycyny Doświadczalnej, 2016: 70, 1142-1149. wskaźnik Impact Factor: 0.690
• Beata Wójcik, Ewa Harasim, Piotr Zabielski, Adrian Chabowski, Jan Górski. Effect of tachycardia on lipid metabolism and expression of fatty acid transporters in heart ventricles of the rat. Journal of Physiology and Pharmacology, 2015: 66, 5, 691-699. Impact Factor: 2.804
• Kamil Kus, Maria Walczak, Edyta Maslak, Agnieszka Zakrzewska, Anna Gonciarz-Dytman, Piotr Zabielski, Barbara Sitek, Krystyna Wandzel, Agnieszka Kij, Adrian Chabowski, Ryan J. Holland, Joseph A. Saavedra, Larry K. Keefer, Stefan Chlopicki. Hepatoselective nitric oxide (NO) donors, V-PYRRO/NO and V-PROLI/NO, in nonalcoholic fatty liver disease: a comparison of antisteatotic effects with the biotransformation and pharmacokinetics. Drug Metabolism and Disposition, 2015: 43, 7, 1028-1036. Impact Factor: 3.210
• Dorota Harasiuk, Marcin Baranowski, Piotr Zabielski, Adrian Chabowski, Jan Górski. LXR agonist T0901317- induced hyperlipidemia does not lead to lipid accumulation in the rat heart. Cellular Physiology and Biochemistry, 2015: 35, 3, 1095-1106. Impact Factor: 4.652